BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mirza N, Stevelink R, Taweel B, Koeleman BPC, Marson AG; International League Against Epilepsy Consortium on Complex Epilepsies . Using common genetic variants to find drugs for common epilepsies. Brain Commun 2021;3:fcab287. [PMID: 34988442 DOI: 10.1093/braincomms/fcab287] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Sun Q, Cao Z, Liu W, Zhang H, Xue Z, Zhao J, Feng Y, Zhao F, Wang J, Wang X. Identification of RNA N6-methyladenosine regulation in epilepsy: Significance of the cell death mode, glycometabolism, and drug reactivity. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1042543] [Reference Citation Analysis]
2 Nwosu G, Reddy SB, Riordan HRM, Kang JQ. Variable Expression of GABAA Receptor Subunit Gamma 2 Mutation in a Nuclear Family Displaying Developmental and Encephalopathic Phenotype. Int J Mol Sci 2022;23. [PMID: 36077081 DOI: 10.3390/ijms23179683] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 International League Against Epilepsy Consortium on Complex Epilepsies, Berkovic SF, Cavalleri GL, Koeleman BP. Genome-wide meta-analysis of over 29,000 people with epilepsy reveals 26 loci and subtype-specific genetic architecture.. [DOI: 10.1101/2022.06.08.22276120] [Reference Citation Analysis]
4 Shlobin NA, Sander JW. Current Principles in the Management of Drug-Resistant Epilepsy. CNS Drugs 2022;36:555-68. [PMID: 35590042 DOI: 10.1007/s40263-022-00922-4] [Reference Citation Analysis]